Gloftamab plus gemcitabine and oxaliplatin (Gloft-GemOx) in patients (pts) with relapsed/refractory difuse large B-cell lymphoma (R/R DLBCL): 2-year (yr) follow-up of STARGLO
Dietrich, S.;
Abramson, J. S.;
Ku, M.;
Hertzberg, M.;
Fox, C. P.;
외 15명
Citations
WEB OF SCIENCE
0
제목
Gloftamab plus gemcitabine and oxaliplatin (Gloft-GemOx) in patients (pts) with relapsed/refractory difuse large B-cell lymphoma (R/R DLBCL): 2-year (yr) follow-up of STARGLO
저자
Dietrich, S.; Abramson, J. S.; Ku, M.; Hertzberg, M.; Fox, C. P.; Herbaux, C.; Yoon, D. H.; Kim, W. S.; Zhang, H.; Abdulhaq, H.; Townsend, W.; Mulvihill, E.; Orellana-Noia, V; Ta, R.; Huang, H.; Kallemeijn, M. J.; Belouso, A.; Bottos, A.; Lundberg, L.; Gregory, G. P.